Prescription Dermatology Therapeutics Market Statistics, Trends Forecast 2032

Prescription Dermatology Therapeutics Market: Industry Perspective

The global prescription dermatology therapeutics market size was worth around USD 26.50 billion in 2023 and is predicted to grow to around USD 42.17 billion by 2032 with a compound annual growth rate (CAGR) of roughly 5.3% between 2024 and 2032.

The report analyzes the global prescription dermatology therapeutics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the prescription dermatology therapeutics industry.

Request Free Sample

The report covers a forecast and an analysis of the prescription dermatology therapeutics market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the prescription dermatology therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the prescription dermatology therapeutics market on a global and regional level.

Dermatology deals with diseases that affect hair, skin, and nails. It involves medical as well as surgical aspects. Skin disorders are treated by a dermatologist. Dermatology medicines are available both over-the-counter and on prescription. Many of the prescription dermatology drugs are used for cosmetic purposes. Acne treatment drugs are the most common type of prescription drugs. These drugs are also used to improve the texture and color of the skin. According to the American Academy of Dermatology, acne is the most prevalent skin condition, which affects nearly 50 million Americans annually.

Intensive research to offer therapies for dermatological disorders, increasing number of people affected with dermatological disorders, efforts taken by leading pharmaceutical companies to offer effective treatments, huge investments made in research and development by pharmaceutical companies, and strategic alliances established by companies to speed up the development process of new products are likely to be major growth factors for the global prescription dermatology therapeutics market. Furthermore, rising disposable income, the growing importance of physical appearance, increasing cases of baldness, a rising number of skilled dermatologists, and increasing spending on personal care are others factors that are anticipated to further propel this market’s growth in the future. A high number of ongoing clinical trials in the field and rapid advancements made in the therapies are estimated to create new growth opportunities for the market players. However, stringent regulations regarding approvals, the high cost of certain specialized medicines, and the absence of insurance and reimbursement policies might restrict the prescription dermatology therapeutics market globally in the near future.

In order to give the users of this report a comprehensive view of the prescription dermatology therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product type launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the prescription dermatology therapeutics market on a global and regional basis.

Prescription Dermatology Therapeutics Market: Segmentation Analysis

The study provides a decisive view of the prescription dermatology therapeutics market by segmenting the market based on product type, distribution channel, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By product type, the prescription dermatology therapeutics market includes psoriasis drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, skin cancer, and fungal infection drugs.

The distribution channel segment includes mail-order pharmacies, retail pharmacies, and hospital pharmacies.

Prescription Dermatology Therapeutics Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa which is further divided into major countries, such as the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Prescription Dermatology Therapeutics Market: Report Scope

Prescription Dermatology Therapeutics Market: Competitive Analysis

Some of the major players in the global prescription dermatology therapeutics market include:

• Novartis AG
• AbbVie, Inc.
• Amgen, Inc.
• Janssen Biotech, Inc.
• Celgene Corporation
• Eli Lilly and Company
• Pfizer, Inc.
• Bausch Health Companies, Inc.
• LEO Pharma A/S
• Aurobindo Pharma Ltd.
• Sun Pharmaceuticals Ltd.
• Aclaris Therapeutics, Inc.

The global prescription dermatology therapeutics market is segmented as follows;

Global Prescription Dermatology Therapeutics Market: By Product Type

• Psoriasis Drugs
• Acne and Rosacea Drugs
• Dermatitis and Seborrhea Drugs
• Skin Cancer
• Fungal Infection Drugs

Global Prescription Dermatology Therapeutics Market: By Distribution Channel

• Mail Order Pharmacies 
• Retail Pharmacies
• Hospital Pharmacies

Global Prescription Dermatology Therapeutics Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa